Piramal Pharma expands into paediatric critical care with UK approval for Neoatricon
Piramal Pharma’s Neoatricon secures UK approval, revolutionizing paediatric critical care. Learn how this breakthrough will reshape neonatal hypotension treatment. Read More
Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and first half (H1) of the fiscal year ... Read More
Piramal Pharma enters men’s grooming market with BOHEM range
Piramal Pharma Limited's Consumer Products Division (CPD) has announced its entry into the men's personal grooming sector, launching the BOHEM product range. This innovative lineup, ... Read More